WVE

Wave Life Sciences Ltd.

5.63 USD
-0.30 (-5.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Wave Life Sciences Ltd. stock is down -11.89% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 8 July’s closed higher than June. 100% of analysts rate it a buy.

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia. It focuses on developing GalNAc-conjugated AIMers to treat hepatic indications.

  • HC Wainwright & Co.
    Wed Jun 26, 08:19
    buy
    confirm
  • Mizuho
    Tue Jun 25, 12:37
    buy
    confirm